MyoSwiss AG is a Zürich-based ETH spin-off founded in 2017 and operating in the Health Care industry. The company's slogan, "Weil Bewegung Lebensqualität ist," demonstrates its commitment to enhancing the quality of life through movement. MyoSwiss is focused on addressing the challenges faced by individuals with muscle weakness, aiming to restore their mobility and independence. The company achieves this through the development of innovative medical devices that combine robotic and textile technology. Its flagship product, the Myosuit, acts as an additional layer of muscle, providing crucial support to the user's movements. In July 2020, MyoSwiss secured a Fr.2.20M investment in a Seed Round, with T-Robotics contributing as the investor. This financial backing serves as a testament to the confidence that industry players have in MyoSwiss' vision and products. By collaborating closely with clinical investigators, MyoSwiss is well-positioned to continue enhancing its offerings and driving impactful change in the field of assistive medical devices. As the company advances, it holds the potential to significantly improve the lives of individuals affected by muscle weakness, reinforcing its position as a compelling investment opportunity in the health care technology sector.
No recent news or press coverage available for MyoSwiss AG.